| 1. |
朱厚玲, 邱紅渝. 抗基底膜抗體腎炎伴抗中性粒細胞胞漿抗體陽性的新月體腎小球腎炎一例. 華西醫學, 2017, 32(5): 795-796.
|
| 2. |
Zhang YY, Tang Z, Chen DM, et al. Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis. BMC Nephrol, 2014, 15: 128.
|
| 3. |
蔣欣欣, 馮劍, 胡衛民, 等. 雙重濾過血漿置換與血漿置換治療重癥自身免疫性疾病的比較研究. 中華危重癥醫學雜志: 電子版, 2010, 3(2): 84-89.
|
| 4. |
Hanafusa N, Kondo Y, Suzuki M, et al. Double filtration plasmapheresis can decrease factor XIII Activity. Ther Apher Dial, 2007, 11(3): 165-170.
|
| 5. |
Jagdish K, Jacob S, Varughese S, et al. Effect of double filtration plasmapheresis on various plasma components and patient safety: a prospective observational cohort study. Indian J Nephrol, 2017, 27(5): 377-383.
|
| 6. |
Chuang YC, Lee CT, Chen JB, et al. Experience in the treatment of myasthenia gravis with double filtration plasmapheresis. Chang Gung Med J, 2000, 23(2): 80-86.
|
| 7. |
李彩鳳. 雙重濾過血漿置換與全血漿置換治療神經系統自身免疫性疾病的療效觀察//2016 年中國中西醫結合學會腎臟疾病專業委員會學術年會論文摘要匯編. 北京: 中國中西醫結合學會腎臟疾病專業委員會, 2016: PU-410.
|
| 8. |
Yeh JH, Chen WH, Huang KM, et al. Prethymectomy plasmapheresis in myasthenia gravis. J Clin Apher, 2005, 20(4): 217-221.
|
| 9. |
Matsuda Y, Tsuda H, Takasaki Y, et al. Double filtration plasmapheresis for the treatment of a rheumatoid arthritis patient with extremely high level of c-reactive protein. Ther Apher Dial, 2004, 8(5): 404-408.
|
| 10. |
Jiang X, Lu M, Ying Y, et al. A case report of double-filtration plasmapheresis for the resolution of refractory chronic urticaria. Ther Apher Dial, 2008, 12(6): 505-508.
|
| 11. |
Szpirt WM, Heaf JG, Petersen J. Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener’s granulomatosis--a clinical randomized controlled trial. Nephrol Dial Transplant, 2011, 26(1): 206-213.
|
| 12. |
De Lind Van Wijngaarden RA, Hauer HA, Wolterbeek R, et al. Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol, 2007, 18(7): 2189-2197.
|
| 13. |
Jayne DR, Gaskin G, Rasmussen N, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol, 2007, 18(7): 2180-2188.
|
| 14. |
Gong D, Ji D, Xu B, et al. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy. Ther Apher Dial, 2013, 17(1): 93-98.
|
| 15. |
Chen Y, Yang L, Li K, et al. Double filtration plasmapheresis in the treatment of antineutrophil cytoplasmic autoantibody associated vasculitis with severe renal failure: a preliminary study of 15 patients. Ther Apher Dial, 2016, 20(2): 183-188.
|
| 16. |
Li M, Wang Y, Qiu Q, et al. Therapeutic effect of double-filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis. J Clin Apher, 2015, 31(4): 375-380.
|
| 17. |
王慧, 鄭智勇. C3 腎小球病研究進展. 臨床與實驗病理學雜志, 2015, 31(4): 439-442.
|
| 18. |
謝軻楠, 陳勁松. 血漿分離技術在腎移植中的應用. 腎臟病與透析腎移植雜志, 2014, 23(6): 573-576.
|
